UniProt ID | TNPO2_HUMAN | |
---|---|---|
UniProt AC | O14787 | |
Protein Name | Transportin-2 | |
Gene Name | TNPO2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 897 | |
Subcellular Localization | Cytoplasm. Nucleus. | |
Protein Description | Probably functions in nuclear protein import as nuclear transport receptor. Serves as receptor for nuclear localization signals (NLS) in cargo substrates. Is thought to mediate docking of the importin/substrate complex to the nuclear pore complex (NPC) through binding to nucleoporin and the complex is subsequently translocated through the pore by an energy requiring, Ran-dependent mechanism. At the nucleoplasmic side of the NPC, Ran binds to the importin, the importin/substrate complex dissociates and importin is re-exported from the nucleus to the cytoplasm where GTP hydrolysis releases Ran. The directionality of nuclear import is thought to be conferred by an asymmetric distribution of the GTP- and GDP-bound forms of Ran between the cytoplasm and nucleus (By similarity).. | |
Protein Sequence | MDWQPDEQGLQQVLQLLKDSQSPNTATQRIVQDKLKQLNQFPDFNNYLIFVLTRLKSEDEPTRSLSGLILKNNVKAHYQSFPPPVADFIKQECLNNIGDASSLIRATIGILITTIASKGELQMWPELLPQLCNLLNSEDYNTCEGAFGALQKICEDSSELLDSDALNRPLNIMIPKFLQFFKHCSPKIRSHAIACVNQFIMDRAQALMDNIDTFIEHLFALAVDDDPEVRKNVCRALVMLLEVRIDRLIPHMHSIIQYMLQRTQDHDENVALEACEFWLTLAEQPICKEVLASHLVQLIPILVNGMKYSEIDIILLKGDVEEDEAVPDSEQDIKPRFHKSRTVTLPHEAERPDGSEDAEDDDDDDALSDWNLRKCSAAALDVLANVFREELLPHLLPLLKGLLFHPEWVVKESGILVLGAIAEGCMQGMVPYLPELIPHLIQCLSDKKALVRSIACWTLSRYAHWVVSQPPDMHLKPLMTELLKRILDGNKRVQEAACSAFATLEEEACTELVPYLSYILDTLVFAFGKYQHKNLLILYDAIGTLADSVGHHLNQPEYIQKLMPPLIQKWNELKDEDKDLFPLLECLSSVATALQSGFLPYCEPVYQRCVTLVQKTLAQAMMYTQHPEQYEAPDKDFMIVALDLLSGLAEGLGGHVEQLVARSNIMTLLFQCMQDSMPEVRQSSFALLGDLTKACFIHVKPCIAEFMPILGTNLNPEFISVCNNATWAIGEICMQMGAEMQPYVQMVLNNLVEIINRPNTPKTLLENTGRLTSPSAIPAITIGRLGYVCPQEVAPMLQQFIRPWCTSLRNIRDNEEKDSAFRGICMMIGVNPGGVVQDFIFFCDAVASWVSPKDDLRDMFYKILHGFKDQVGEDNWQQFSEQFPPLLKERLAAFYGV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
25 | Phosphorylation | KDSQSPNTATQRIVQ HCCCCCCHHHHHHHH | 34.17 | - | |
34 | Ubiquitination | TQRIVQDKLKQLNQF HHHHHHHHHHHHHCC | 40.26 | - | |
57 | Phosphorylation | FVLTRLKSEDEPTRS HHHHCCCCCCCCCCC | 55.67 | 21406692 | |
57 (in isoform 2) | Phosphorylation | - | 55.67 | 21406692 | |
64 | Phosphorylation | SEDEPTRSLSGLILK CCCCCCCCCCCCHHH | 29.39 | 21406692 | |
64 (in isoform 2) | Phosphorylation | - | 29.39 | 21406692 | |
66 | Phosphorylation | DEPTRSLSGLILKNN CCCCCCCCCCHHHCC | 32.57 | 30108239 | |
71 (in isoform 2) | Ubiquitination | - | 39.21 | 21890473 | |
71 | Malonylation | SLSGLILKNNVKAHY CCCCCHHHCCHHHHH | 39.21 | 33225896 | |
71 | Acetylation | SLSGLILKNNVKAHY CCCCCHHHCCHHHHH | 39.21 | 25953088 | |
71 (in isoform 1) | Ubiquitination | - | 39.21 | 21890473 | |
71 | Ubiquitination | SLSGLILKNNVKAHY CCCCCHHHCCHHHHH | 39.21 | 21906983 | |
75 | Ubiquitination | LILKNNVKAHYQSFP CHHHCCHHHHHHCCC | 31.41 | - | |
102 | Phosphorylation | NNIGDASSLIRATIG HHCCCHHHHHHHHHH | 29.54 | 24719451 | |
182 | Acetylation | PKFLQFFKHCSPKIR HHHHHHHHHCCHHHH | 45.02 | 25953088 | |
254 | Phosphorylation | RLIPHMHSIIQYMLQ HHHHHHHHHHHHHHH | 17.51 | 30631047 | |
258 | Phosphorylation | HMHSIIQYMLQRTQD HHHHHHHHHHHHCCC | 6.87 | 30631047 | |
334 (in isoform 2) | Ubiquitination | - | 38.13 | 21890473 | |
334 | Ubiquitination | PDSEQDIKPRFHKSR CCCHHCCCCCCCCCC | 38.13 | 21906983 | |
334 (in isoform 1) | Ubiquitination | - | 38.13 | 21890473 | |
340 | Phosphorylation | IKPRFHKSRTVTLPH CCCCCCCCCEEECCC | 25.31 | 21406692 | |
342 | Phosphorylation | PRFHKSRTVTLPHEA CCCCCCCEEECCCCC | 25.57 | 20873877 | |
344 | Phosphorylation | FHKSRTVTLPHEAER CCCCCEEECCCCCCC | 33.68 | 20873877 | |
355 (in isoform 2) | Phosphorylation | - | 39.42 | 21406692 | |
355 | Phosphorylation | EAERPDGSEDAEDDD CCCCCCCCCCCCCCC | 39.42 | 23898821 | |
368 | Phosphorylation | DDDDDALSDWNLRKC CCCCCCHHHHHHHHH | 42.15 | 20873877 | |
374 | Ubiquitination | LSDWNLRKCSAAALD HHHHHHHHHHHHHHH | 35.39 | - | |
376 | Phosphorylation | DWNLRKCSAAALDVL HHHHHHHHHHHHHHH | 24.79 | 24114839 | |
458 | Phosphorylation | VRSIACWTLSRYAHW HHHHHHHHHHHHCHH | 18.10 | 20071362 | |
484 (in isoform 1) | Ubiquitination | - | 50.44 | 21890473 | |
484 (in isoform 2) | Ubiquitination | - | 50.44 | 21890473 | |
484 | Ubiquitination | PLMTELLKRILDGNK HHHHHHHHHHHCCCH | 50.44 | 21890473 | |
484 | Ubiquitination | PLMTELLKRILDGNK HHHHHHHHHHHCCCH | 50.44 | - | |
683 | Phosphorylation | SMPEVRQSSFALLGD CCHHHHHHHHHHHHH | 19.50 | 21712546 | |
684 | Phosphorylation | MPEVRQSSFALLGDL CHHHHHHHHHHHHHH | 13.24 | 21712546 | |
760 | Phosphorylation | EIINRPNTPKTLLEN HHHCCCCCCCHHHHH | 28.92 | 25599653 | |
817 | Acetylation | NIRDNEEKDSAFRGI CCCCCCCCCCHHHHH | 51.29 | 26822725 | |
817 | Ubiquitination | NIRDNEEKDSAFRGI CCCCCCCCCCHHHHH | 51.29 | - | |
852 (in isoform 2) | Acetylation | - | 34.18 | - | |
862 | Ubiquitination | DLRDMFYKILHGFKD HHHHHHHHHHHHCHH | 27.76 | 2189047 | |
862 | Acetylation | DLRDMFYKILHGFKD HHHHHHHHHHHHCHH | 27.76 | 19608861 | |
868 | Ubiquitination | YKILHGFKDQVGEDN HHHHHHCHHCCCCCC | 52.41 | - | |
888 | Ubiquitination | EQFPPLLKERLAAFY HHCCHHHHHHHHHHH | 48.77 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TNPO2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TNPO2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TNPO2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
A1CF_HUMAN | A1CF | physical | 12896982 | |
NUP98_HUMAN | NUP98 | physical | 10875935 | |
NXF1_HUMAN | NXF1 | physical | 12384575 | |
MTNB_HUMAN | APIP | physical | 25416956 | |
CA094_HUMAN | C1orf94 | physical | 25416956 | |
PNMA5_HUMAN | PNMA5 | physical | 25416956 | |
TBB5_HUMAN | TUBB | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-862, AND MASS SPECTROMETRY. |